{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T19:05:43Z","timestamp":1726427143678},"reference-count":21,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.dld.2007.03.010","type":"journal-article","created":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T03:55:33Z","timestamp":1196481333000},"page":"785-790","source":"Crossref","is-referenced-by-count":5,"title":["Recurrent myocardial ischaemia during combination antiviral therapy in a patient with chronic hepatitis C and normal aminotransferase levels"],"prefix":"10.1016","volume":"40","author":[{"given":"I.","family":"Lenci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Piccolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Francioso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Di Paolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Galante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Angelico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.dld.2007.03.010_bib1","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1002\/hep.1840360723","article-title":"Treatment of patients with hepatitis C and normal serum aminotransferase levels","volume":"36","author":"Bacon","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2007.03.010_bib2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/gast.1996.v110.pm8536870","article-title":"Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity","volume":"110","author":"Serfaty","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2007.03.010_bib3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0002-9343(00)00381-8","article-title":"Liver biopsy in the evaluation of patients with chronic hepatitis C who have repeatedly normal or near normal serum alanine aminotransferase","volume":"109","author":"Nutt","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.dld.2007.03.010_bib4","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jhep.2005.03.032","article-title":"Chronic hepatitis C and normal ALT levels: treat the disease not the test","volume":"43","author":"Puoti","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2007.03.010_bib5","doi-asserted-by":"crossref","first-page":"961","DOI":"10.7326\/0003-4819-137-12-200212170-00009","article-title":"Prevalence of liver disease in a population of asymptomatic person with hepatitis C virus infection","volume":"137","author":"Alberti","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2007.03.010_bib6","first-page":"1788","article-title":"Chronic hepatitis C with normal aminotransferase levels: a clinical histologic study","volume":"92","author":"Gholson","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2007.03.010_bib7","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alpha 2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2007.03.010_bib8","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","article-title":"Peginterferon-alpha 2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose","volume":"140","author":"Hadziyannis","year":"2004","journal-title":"Ann Int Med"},{"key":"10.1016\/j.dld.2007.03.010_bib9","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1053\/j.gastro.2004.09.050","article-title":"Peginterferon alpha 2a (40 Kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels","volume":"127","author":"Zeuzem","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2007.03.010_bib10","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/hep.1840360703","article-title":"National Institute of Heath Consensus Development Conference Statement: management of hepatitis C: 2002 June 10\u201312","volume":"36","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2007.03.010_bib11","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/hep.20119","article-title":"Diagnosis, management and treatment of hepatitis C","volume":"39","author":"Strader","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2007.03.010_bib12","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0016-5085(00)70145-4","article-title":"Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels","volume":"118","author":"Persico","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2007.03.010_bib13","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1053\/gast.2001.30115","article-title":"Is the natural history of HCV carriers with normal aminotransferase levels really benign?","volume":"121","author":"Cividini","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2007.03.010_bib14","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/hep.510270333","article-title":"Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity","volume":"27","author":"Mathurin","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2007.03.010_bib15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0168-8278(03)00004-7","article-title":"A comparison in the progression of liver fibrosis in chronic hepatitis C between persistently normal and elevated transaminase","volume":"38","author":"Hui","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2007.03.010_bib16","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/hrt.2003.018937","article-title":"Evidence for association between hepatitis C virus seropositivity and coronary artery disease","volume":"90","author":"Vassalle","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.dld.2007.03.010_bib17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1253\/circj.67.26","article-title":"Association between hepatitis C virus core protein and carotid atherosclerosis","volume":"67","author":"Ishizaka","year":"2003","journal-title":"Circ J"},{"key":"10.1016\/j.dld.2007.03.010_bib18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0140-6736(02)07339-7","article-title":"Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening","volume":"359","author":"Ishizaka","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2007.03.010_bib19","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1161\/01.CIR.103.8.1064","article-title":"Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study","volume":"103","author":"Kiechl","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.dld.2007.03.010_bib20","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1086\/507031","article-title":"No association between hepatitis C virus seropositivity and acute myocardial infarction","volume":"43","author":"Arcari","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.dld.2007.03.010_bib21","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0140-6736(97)03079-1","article-title":"Chronic infections and coronary heart disease: is there a link?","volume":"350","author":"Danesh","year":"1997","journal-title":"Lancet"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086580700134X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086580700134X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T16:28:11Z","timestamp":1546446491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S159086580700134X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S159086580700134X"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2007.03.010","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}